|
|
Article: Advanced Viral Research Corp. Announces A Peptide Nucleic Acid (PNA) Human AIDS Trial Underway
- Article from:
- PR Newswire
- Article date:
- September 4, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HALLANDALE, Fla., Sept. 4 /PRNewswire/ -- Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) of Hallandale, FL. has received in writing that a double blind clinical AIDS trial assessing the efficacy of the drug Reticulose in human patients with AIDS is currently underway. The study is taking place at the School of Clinical Medicine and Research, University of the West Indies, based at the Queen Elizabeth Hospital (QEH) in Bridgetown, Barbados.
This clinical study was undertaken following the laboratory investigations of Dr. Hirschman, showing that Reticulose (PNA) inhibits the replication of HIV and stimulates the immune system to produce immuno-modulators ...